{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:20:37Z","timestamp":1777486837427,"version":"3.51.4"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Supplement 3S","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1097\/tp.0000000000001094","type":"journal-article","created":{"date-parts":[[2016,2,20]],"date-time":"2016-02-20T14:02:26Z","timestamp":1455976946000},"page":"S1-S4","source":"Crossref","is-referenced-by-count":23,"title":["Cytomegalovirus Immunoglobulin After Thoracic Transplantation"],"prefix":"10.1097","volume":"100","author":[{"given":"Paolo","family":"Grossi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Mohacsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zolt\u00e1n","family":"Szabolcs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciano","family":"Potena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-1-20210129","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1111\/ajt.12725","article-title":"New cell-signaling pathways for controlling cytomegalovirus replication.","volume":"14","author":"Roy","year":"2014","journal-title":"Am J Transplant"},{"key":"R2-1-20210129","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0966-842X(02)02393-4","article-title":"Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion.","volume":"10","author":"Mocarski","year":"2002","journal-title":"Trends Microbiol"},{"key":"R3-1-20210129","doi-asserted-by":"crossref","first-page":"11030","DOI":"10.1128\/JVI.78.20.11030-11039.2004","article-title":"Human cytomegalovirus infection induces rapamycin-insensitive phosphorylation of downstream effectors of mTOR kinase.","volume":"79","author":"Kudchodkar","year":"2004","journal-title":"J Virol"},{"key":"R4-1-20210129","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1399-0012.2007.00750.x","article-title":"CMV-hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta-analysis.","volume":"22","author":"Bonaros","year":"2008","journal-title":"Clin Transplant"},{"key":"R5-1-20210129","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/ajt.12181","article-title":"Everolimus versus mycophenolate mofetil in heart transplantation: a randomized, multicenter trial.","volume":"13","author":"Eisen","year":"2013","journal-title":"Am J Transplant"},{"key":"R6-1-20210129","first-page":"88","article-title":"Does the calcineurin inhibitor have influence on cytomegalovirus infection in heart transplantation Clin Transplant.","volume":"28","author":"Rodriguez-Serrano","year":"2014","journal-title":""},{"key":"R7-1-20210129","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/ajt.12809","article-title":"SCHEDULE Investigators Everolimus initiation and early calcineurin inhibitor withdrawal in heart transplant recipients: a randomized trial.","volume":"14","author":"Andreassen","year":"2014","journal-title":"Am J Transplant"},{"key":"R8-1-20210129","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2147\/DDDT.S36578","article-title":"Effects of oral valganciclovir prophylaxis for cytomegalovirus infection in heart transplant patients.","volume":"6","author":"Doesch","year":"2012","journal-title":"Drug Des Devel Ther"},{"key":"R9-1-20210129","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/TP.0000000000000160","article-title":"Members of Swiss Transplant Cohort Study Cytomegalovirus serology and replication remain associated with solid organ graft rejection and graft loss in the era of prophylactic treatment.","volume":"98","author":"Stern","year":"2014","journal-title":"Transplantation"},{"key":"R10-1-20210129","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1186\/1471-2334-13-582","article-title":"Lower incidence of CMV infection and acute rejections with valganciclovir prophylaxis in lung transplant recipients.","volume":"13","author":"Johansson","year":"2013","journal-title":"BMC Infect Dis"},{"key":"R11-1-20210129","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.healun.2010.04.022","article-title":"Cytomegalovirus disease among donor-positiverecipient-negative lung transplant recipients in the era of valganciclovir prophylaxis.","volume":"29","author":"Mitsani","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"R12-1-20210129","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.healun.2013.04.010","article-title":"Decreased incidence of cytomegalovirus infection with sirolimus in a post hoc randomized, multicenter study in lung transplantation.","volume":"32","author":"Ghassemieh","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"R13-1-20210129","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/tid.12007","article-title":"Everolimus is associated with a reduced incidence of cytomegalovirus infection following de novo cardiac transplantation.","volume":"15","author":"Kobashigawa","year":"2013","journal-title":"Transpl Infect Dis"},{"key":"R14-1-20210129","doi-asserted-by":"crossref","first-page":"761","DOI":"10.7326\/0003-4819-152-12-201006150-00003","article-title":"Extended valganciclovir prophylaxis to prevent cytomegalovirus after lung transplantation: a randomized, controlled trial.","volume":"152","author":"Palmer","year":"2010","journal-title":"Ann Intern Med"},{"key":"R15-1-20210129","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/TP.0b013e31829df29d","article-title":"Updated international consensus guidelines on the management of cytomegalovirus in solid-organ.","volume":"96","author":"Kotton","year":"2013","journal-title":"Transplantation"},{"key":"R16-1-20210129","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1034\/j.1399-3062.1999.010205.x","article-title":"Cytomegalovirus infection and cardiac allograft vasculopathy.","volume":"1","author":"Koskinen","year":"1999","journal-title":"Transpl Infect Dis"},{"key":"R17-1-20210129","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.healun.2009.02.009","article-title":"Prophylaxis versus preemptive anti-cytomegalovirus approach for prevention of allograft vasculopathy in heart transplant recipients.","volume":"28","author":"Potena","year":"2009","journal-title":"J Heart Lung Transplant"},{"issue":"Suppl 2","key":"R19-1-20210129","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1034\/j.1399-3062.2001.00009.x","article-title":"Role of cytomegalovirus in cardiac allograft vasculopathy.","volume":"3","author":"Weill","year":"2001","journal-title":"Transpl Infect Dis"},{"key":"R20-1-20210129","first-page":"724","article-title":"Cytomegalovirus infection and accelerated cardiac allograft vasculopathy in human cardiac allografts.","volume":"12","author":"Koskinen","year":"1993","journal-title":"J Heart Lung Transplant"},{"key":"R21-1-20210129","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1111\/j.1600-6143.2011.03663.x","article-title":"Cytomegalovirus replication within the lung allograft is associated with bronchiolitis obliterans syndrome.","volume":"11","author":"Paraskeva","year":"2011","journal-title":"Am J Transplant"},{"key":"R22-1-20210129","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1164\/rccm.200911-1786OC","article-title":"Cytomegalovirus pneumonitis is a risk for bronchiolitis obliterans syndrome in lung transplantation.","volume":"181","author":"Snyder","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"R23-1-20210129","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1164\/ajrccm\/146.6.1419","article-title":"Sequelae of cytomegalovirus pulmonary infections in lung allograft recipients.","volume":"146","author":"Duncan","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"R24-1-20210129","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3109\/00365540903341828","article-title":"Cytomegalovirus and long-term outcome after lung transplantation in Gothenburg, Sweden.","volume":"42","author":"Johansson","year":"2010","journal-title":"Scand J Infect Dis"},{"key":"R25-1-20210129","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1086\/528689","article-title":"Ganciclovirvalganciclovir prophylaxis decreases cytomegalovirus-related events and bronchiolitis obliterans syndrome after lung transplantation.","volume":"46","author":"Chmiel","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R26-1-20210129","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1097\/00007890-199312000-00043","article-title":"In vitro induction of endothelial HLA class II antigen expression by CMV-activated CD4 T cells.","volume":"56","author":"Waldman","year":"1993","journal-title":"Transplantation"},{"key":"R27-1-20210129","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/01.TP.0000113444.58944.41","article-title":"Platelet-derived growth factor regulates cytomegalovirus infection-enhanced obliterative bronchiolitis in rat tracheal allograft.","volume":"77","author":"Tikkanen","year":"2004","journal-title":"Transplantation"},{"key":"R28-1-20210129","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1097\/TP.0b013e3181a492e8","article-title":"The risk, prevention, and outcome of cytomegalovirus after pediatric lung transplantation.","volume":"87","author":"Danziger-Isakov","year":"2009","journal-title":"Transplantation"},{"key":"R29-1-20210129","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s00705-013-1607-9","article-title":"Detection of human cytomegalovirus in transbronchial biopsies from lung transplant recipients.","volume":"158","author":"Costa","year":"2013","journal-title":"Arch Virol"},{"key":"R30-1-20210129","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/tid.12015","article-title":"Clinical significance of quantitative cytomegalovirus detection in bronchoalveolar lavage fluid in lung transplant recipients.","volume":"15","author":"Schlischewsky","year":"2013","journal-title":"Transpl Infect Dis"},{"issue":"Suppl 3","key":"R31-1-20210129","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.transproceed.2011.02.069","article-title":"Update and review: state-of-the art management of cytomegalovirus infection and disease following thoracic organ transplantation.","volume":"43","author":"Snydman","year":"2011","journal-title":"Transplant Proc"},{"key":"R33-1-20210129","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1097\/TP.0b013e3181ffba7e","article-title":"Cytomegalovirus prevention and long-term recipient and graft survival in pediatric heart transplant patients.","volume":"90","author":"Snydman","year":"2010","journal-title":"Transplantation"},{"key":"R34-1-20210129","doi-asserted-by":"crossref","first-page":"E455","DOI":"10.1111\/j.1399-0012.2011.01459.x","article-title":"The impact of CMV prevention on long-term recipient and graft survival in heart transplant recipients: analysis of the Scientific Registry of Transplant Recipients (SRTR) database.","volume":"25","author":"Snydman","year":"2011","journal-title":"Clin Transplant"},{"key":"R35-1-20210129","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/TP.0b013e3181ea3955","article-title":"An international survey of cytomegalovirus management practices in lung.","volume":"90","author":"Zuk","year":"2010","journal-title":"Transplantation"},{"key":"R36-1-20210129","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1097\/TP.0b013e31828ee12e","article-title":"International survey of cytomegalovirus management in solid organ transplantation after the publication of consensus guidelines.","volume":"95","author":"Le Page","year":"2013","journal-title":"Transplantation"},{"key":"R37-1-20210129","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1097\/TP.0b013e3181ff1493","article-title":"Extended valganciclovir prophylaxis in DR kidney transplant recipients is associated with long-term reduction in cytomegalovirus disease: two-year results of the IMPACT study.","volume":"90","author":"Humar","year":"2010","journal-title":"Transplantation"},{"key":"R38-1-20210129","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.healun.2008.02.002","article-title":"High incidence of cytomegalovirus disease in DR heart transplant recipients shortly after completion of 3 months of valganciclovir prophylaxis.","volume":"27","author":"Gupta","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"R39-1-20210129","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1111\/j.1600-6143.2004.00571.x","article-title":"Following universal prophylaxis with intravenous ganciclovir and cytomegalovirus immune globulin, valganciclovir is safe and effective for prevention of CMV infection following lung transplantation.","volume":"4","author":"Zamora","year":"2004","journal-title":"Am J Transplant"},{"key":"R40-1-20210129","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.healun.2009.03.012","article-title":"Cytomegalovirus prevention in high-risk lung transplant recipients: comparison of 3- vs 12-month valganciclovir therapy.","volume":"28","author":"Jaksch","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"R41-1-20210129","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.healun.2011.02.017","article-title":"Long-term efficacy and safety of 12 months of valganciclovir prophylaxis compared with 3 months after lung transplantation: a single-center, long-term follow-up analysis from a randomized, controlled cytomegalovirus prevention trial.","volume":"30","author":"Finlen Copeland","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"R42-1-20210129","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1053-2498(03)00200-6","article-title":"Comparison of intravenous ganciclovir and cytomegalovirus hyperimmune globulin pre-emptive treatment in cytomegalovirus-positive heart transplant recipients.","volume":"23","author":"Vrtovec","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"R43-1-20210129","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1111\/j.1600-6143.2012.04087.x","article-title":"Cytomegalovirus replication kinetics in solid organ transplant recipients managed by preemptive therapy.","volume":"12","author":"Atabani","year":"2012","journal-title":"Am J Transplant"},{"key":"R44-1-20210129","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.healun.2007.07.016","article-title":"Clinical features and outcomes of delayed-onset primary cytomegalovirus disease in cardiac transplant recipients.","volume":"26","author":"Kijpittayarit-Arthurs","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"R45-1-20210129","first-page":"376","article-title":"Late-onset cytomegalovirus (CMV) in lung transplant recipients: can CMV serostatus guide the duration of prophylaxis Am J Transplant.","volume":"13","author":"Schoeppler","year":"2013","journal-title":""},{"key":"R46-1-20210129","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jcv.2012.04.019","article-title":"Sensitive and rapid detection of ganciclovir resistance by PCR based MALDI-TOF analysis.","volume":"54","author":"Zurcher","year":"2012","journal-title":"J Clin Virol"},{"key":"R47-1-20210129","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2165\/00003495-200161080-00016","article-title":"Ganciclovir: an update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients.","volume":"61","author":"McGavin","year":"2001","journal-title":"Drugs"},{"key":"R48-1-20210129","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/j.1600-6143.2009.02617.x","article-title":"VICTOR Study Group Long-term outcomes of CMV disease treatment with valganciclovir versus IV ganciclovir in solid organ transplant recipients.","volume":"9","author":"Asberg","year":"2009","journal-title":"Am J Transplant"},{"key":"R49-1-20210129","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S1053-2498(02)00474-6","article-title":"Long-term results of CMV hyperimmune globulin prophylaxis in 377 heart transplant recipients.","volume":"22","author":"Kocher","year":"2003","journal-title":"J Heart Lung Transplant"},{"key":"R50-1-20210129","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1128\/AAC.39.7.1643","article-title":"Prospective randomized trial of efficacy of ganciclovir versus that of anti-cytomegalovirus (CMV) immunoglobulin to prevent CMV disease in CMV-seropositive heart transplant recipients treated with OKT3.","volume":"39","author":"Aguado","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"R52-1-20210129","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/jcp.43.5.373","article-title":"Management of cytomegalovirus antibody negative patients undergoing heart transplantation.","volume":"43","author":"Freeman","year":"1990","journal-title":"J Clin Pathol"},{"key":"R53-1-20210129","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1423-0410.2009.01226.x","article-title":"Intravenous immunoglobulin G: trends in production methods, quality control and quality assurance.","volume":"98","author":"Radosevich","year":"2010","journal-title":"Vox Sang"},{"issue":"Suppl 4","key":"R54-1-20210129","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1111\/j.1600-6143.2009.02897.x","article-title":"AST Infectious Diseases Community of Practice. Cytomegalovirus in solid organ transplant recipients.","volume":"9","author":"Humar","year":"2009","journal-title":"Am J Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000001094","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T14:02:23Z","timestamp":1718373743000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201603001-00001"}},"subtitle":["An Overview"],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":51,"journal-issue":{"issue":"Supplement 3S","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000001094","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}